Rare bone tumor under the microscope: can we predict its behavior?

NCT ID NCT07360964

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study gathers information from 77 Italian patients with a rare, low-grade bone tumor called clear cell chondrosarcoma. Researchers will review medical records, imaging, and tissue samples to find patterns that might predict whether the tumor will come back or spread. The goal is to create a model that helps doctors better estimate a patient's outlook, but no new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could provide doctors with better tools to predict how this rare bone tumor will behave, helping guide treatment decisions.

What could go wrong

This is an observational study, not a treatment trial. It looks back at past cases, so results may not apply to future patients. The small number of cases (77) limits how much we can learn.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chondrosarcoma Chondrosarcoma, Clear Cell clear cell chondrosarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IRCC Rizzoli Orthopedic Institute

    Bologna, 40136, Italy